Recall of blood pressure medications expanded for 5th time due to possible cancer risk
Federal health officials said a recall for medication used to treat high blood pressure has been expanded for a fifth time after trace amounts of a possible cancer-causing substance were detected.
Torrent Pharmaceuticals Limited announced its expanded recall Thursday for losartan potassium tablets USP and losartan potassium/hydrochlorothiazide tablets, USP, due to the detection of trace amounts of an "unexpected impurity" while testing finished product batches, according to the U.S. Food and Drug Administration.
The substance, called N-Methylnitrosobutyric acid or NMBA, is a "probable human carcinogen," according to the FDA.
The medication is used to treat hypertension, hypertensive patients with left ventricular hypertrophy and nephropathy in Type 2 diabetic patients, the FDA said.
Federal health officials said patients should continue taking their medication as the risk of harm may be higher if the treatment is stopped immediately without an alternative. Patients should also contact their doctor about an alternative treatment.RELATED: Generic Zantac makers halt worldwide distribution after FDA finds possible cancer chemical in drugs
The medication under the expanded recall can be identified by checking the product name, manufacturer details and batch or lot number on the bottle, the FDA said. A full product list is available online.
Drugmakers have issued dozens of recalls since July linked to low levels of the probable cancer-causing chemical.
The affected medications are low-cost versions of lifesaving heart-regulating drugs, including valsartan, losartan and irbesartan. They are designed to allow blood to flow more easily and are sold as single-ingredient pills and tablets and in combination with other drugs.This story was reported from Cincinnati. The Associated Press contributed.
Blood pressure medicine from Torrent Pharma has been recalled for the fifth time after trace amounts of the cancer-causing impurities were found in the pills. Three lots of Losartan Potassium tablets and two lots of
A recall of certain blood pressure medications expanded after tests found a potentially cancer-causing chemical, according to the Food and Drug Administration. The FDA reports that some lots of Torrent Pharmaceuticals Limited's Losartan Potassium Tablets USP
CLOSE A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the drug, federal health officials said. Three
Interruptions continue to wreak havoc on the global drug supply as drugmakers respond to the detection of impurities that are produced during manufacturing of some commonly used prescription and over-the-counter meds. India's Dr. Reddy's joined
The Food and Drug Administration has announced another round of recalls related to high blood pressure medications. Torrent Pharmaceuticals Limited is recalling batches of Losartan Potassium tablets due to "trace amounts" of N-Methylnitrosobutyric acid, a known
Torrent Pharmaceuticals Limited has expanded its voluntary recall of losartan potassium tablets after finding trace amounts of an "unexpected impurity." The expanded recall includes an additional three lots of losartan potassium tablets USP and two
The Food and Drug Administration has again expanded a recall for medication used to treat high blood pressure. Torrent Pharmaceutical Limited is recalling certain lots of Losartan Potassium tablets. The medication is used to treat hypertension,
More News in Phoenix
Joker actor Joaquin Phoenix walked out of an interview promoting his new film after he was asked if dark scenes could inspire real life violence. The Telegraph reports the actor, 44,
Amy Sussman / Staff / Getty Images This article has been changed since its original publication. Though the early critical buzz for the upcoming comic book movie "Joker" has been generally
Rave reviews are still flying in for Joker as the film is still a couple of weeks away from release. One thing that the reviews seem to mention a lot so far is how haunting
Joker actor Joaquin Phoenix walked out of an interview promoting his new film after he was asked if dark scenes could inspire real life violence. The Telegraph reports the actor, 44, muttered "why would you..?" before
Joaquin Phoenix walked out of an interview when asked to respond to concerns about onscreen violence in his new film, "Joker," which tells the origin story of the DC comic book villain. For an article